USP9X inhibition improves gemcitabine sensitivity in pancreatic cancer by inhibiting autophagy is a research paper published in Cancer Letters (2018). On theSindex it has a DataRank of 2.7. It has been cited 69 times, with 64 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.637
From this paper's citation signal
Citation Network Contribution
2.1
From 58 citing papers with measurable signal
National High Technology Research and Development
Grant: SS2015AA020405
National High Technology Research and Development
Grant: SS2014AA020533
Zhejiang Provincial Natural Science Foundation of China
Grant: LQ13H160006
Diagnosis and Treatment of Pancreatic Cancer of Zhejiang Province
Grant: 2013TD06
National Natural Science Foundation of China
Grant: 81530079
National Natural Science Foundation of China
Grant: 81300341
National Natural Science Foundation of China
Grant: 81302071
National Natural Science Foundation of China
Grant: 81401954
FWCI
4.06
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of miR-101-3p-mediated role of PDZK1 in hepatocellular carcinoma progression and the underlying PI3K/Akt signaling mechanism
Additional file 1 of miR-101-3p-mediated role of PDZK1 in hepatocellular carcinoma progression and the underlying PI3K/Akt signaling mechanism
Additional file 2 of miR-101-3p-mediated role of PDZK1 in hepatocellular carcinoma progression and the underlying PI3K/Akt signaling mechanism
Additional file 2 of miR-101-3p-mediated role of PDZK1 in hepatocellular carcinoma progression and the underlying PI3K/Akt signaling mechanism